Koninklijke Philips (NYSE:PHG) Posts Earnings Results, Beats Expectations By $0.03 EPS

Key Points

• Philips beat Q1 expectations with $0.27 EPS vs. $0.24 and revenue of $4.52B vs. $4.49B, reported order intake +6% and comparable sales ~+3.7–4%, and reiterated full‑year guidance for 3–4.5% sales growth, 12.5–13% adjusted EBITDA margin and €1.3–1.5bn free cash flow.
• Management highlighted accelerating innovation and regulatory momentum—including 25 510(k)/PMAs in Q1 and an industry‑first helium‑free 3T MRI targeting 2027 clearance—which should support higher‑margin product uptake.
• Headwinds persist as China’s centralized procurement is pressuring CT/ultrasound pricing (Philips now expects China sales to be broadly stable for 2026) and tariffs/freight/components raise costs, though Philips reported €126m of Q1 productivity toward a €1.5bn three‑year target and kept its full‑year outlook intact despite near‑term margin risk.

Koninklijke Philips (NYSE:PHG - Get Free Report) posted its earnings results on Wednesday. The technology company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.03, FiscalAI reports. Koninklijke Philips had a net margin of 5.09% and a return on equity of 13.68%. The firm had revenue of $4.52 billion during the quarter, compared to analyst estimates of $4.49 billion.

Here are the key takeaways from Koninklijke Philips' conference call:

• Philips reported strong Q1 momentum with order intake +6%, comparable sales up (around +3.7–4%) and adjusted EBITDA margin improving 40 bps to 9%, and the company reiterated its full‑year guidance of 3–4.5% sales growth, 12.5–13% adj. EBITDA margin and €1.3–1.5bn free cash flow.
• Management highlighted accelerating innovation and regulatory momentum—25 510(k)/PMAs in Q1 (more than double YoY)—including helium‑free MR leadership (industry‑first helium‑free 3T targeting 2027 clearance), Verida spectral CT, SmartHeart and DeviceGuide, which support higher-margin product uptake.
• China remains a drag as expanding centralized procurement is pressuring CT and ultrasound pricing and order conversion, contributing to weakness in Precision Diagnosis and leading Philips to assume China sales will be broadly stable rather than growth for 2026.
• Cost pressures from tariffs, freight, electronic components and plastics persist, but Philips reported €126m of Q1 productivity toward a €1.5bn three‑year target and says mitigation (AI, BOM savings, selective pricing) is underway though largely back‑end loaded, implying near‑term margin pressure (Q2) but unchanged full‑year outlook.

Koninklijke Philips Price Performance

Koninklijke Philips stock traded up $0.74 during midday trading on Wednesday, reaching $27.19. The company had a trading volume of 3,327,696 shares, compared to its average volume of 1,085,984. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.32 and a quick ratio of 0.94. Koninklijke Philips has a 12-month low of $21.95 and a 12-month high of $33.44. The company has a market capitalization of $26.18 billion, a P/E ratio of 25.65, a P/E/G ratio of 6.87 and a beta of 0.74. The firm's fifty day simple moving average is $28.27 and its 200-day simple moving average is $28.43.

Koninklijke Philips Increases Dividend

The business also recently declared an annual dividend, which will be paid on Wednesday, June 3rd. Investors of record on Wednesday, May 13th will be given a dividend of $1.013 per share. This is a boost from Koninklijke Philips's previous annual dividend of $0.89. The ex-dividend date is Wednesday, May 13th. This represents a dividend yield of 318.0%. Koninklijke Philips's payout ratio is currently 77.36%.

Analyst Ratings Changes

PHG has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of Koninklijke Philips from a "hold" rating to a "buy" rating in a report on Saturday. Zacks Research cut Koninklijke Philips from a "strong-buy" rating to a "hold" rating in a report on Monday, April 13th. Finally, Weiss Ratings downgraded Koninklijke Philips from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Thursday, April 2nd. Four equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Koninklijke Philips has an average rating of "Hold".

Key Koninklijke Philips News

Here are the key news stories impacting Koninklijke Philips this week:

• Positive Sentiment: Q1 earnings beat and revenue upside — Philips reported $0.27 EPS vs. $0.24 consensus and €4.52B revenue vs. €4.49B expected, a clear earnings surprise that supports near-term upside. MarketBeat Q1 results
• Positive Sentiment: Order intake and comparable sales growth — Comparable order intake rose ~6% with comparable sales up ~4%, led by North America and Europe, indicating demand momentum across key markets. GlobeNewswire Q1 release
• Positive Sentiment: Margin expansion and guidance maintained — Adjusted EBITA/EBITDA metrics expanded (EBITA margin +40 bps) and Philips reiterated 2026 guidance for ~3–4.5% sales growth and a 12.5–13% adjusted EBITDA margin, reducing execution risk. MSN: Outlook reiterated
• Neutral Sentiment: Geographic demand mix — Management highlighted strong Western Europe and North American order growth, which supports revenue quality but increases exposure to U.S. tariffs/policy shifts. Reuters Q1 coverage
• Neutral Sentiment: Management actions on tariffs — CEO Roy Jakobs said Philips will ask the U.S. administration for a tariff rebate; this could help margins if successful but timing and outcome are uncertain. YouTube: CEO on tariff rebate
• Negative Sentiment: Cash flow and execution risk — Operating cash flow was positive but free cash flow was modest (EUR 28M), leaving limited near-term balance-sheet cushion if macro costs rise. GlobeNewswire cash flow details
• Negative Sentiment: Inflation and tariff headwinds remain — Management flagged inflationary pressure and tariffs as ongoing headwinds that require disciplined execution to hit full-year targets. TipRanks call highlights

Hedge Funds Weigh In On Koninklijke Philips

A number of hedge funds have recently made changes to their positions in PHG. Morgan Stanley boosted its stake in shares of Koninklijke Philips by 11.0% in the fourth quarter. Morgan Stanley now owns 2,841,880 shares of the technology company's stock worth $76,958,000 after acquiring an additional 282,661 shares during the last quarter. Moore Capital Management LP purchased a new position in Koninklijke Philips in the 4th quarter valued at $5,727,000. Morningstar Investment Management LLC acquired a new stake in Koninklijke Philips during the 3rd quarter worth $5,434,000. Tower Research Capital LLC TRC grew its holdings in shares of Koninklijke Philips by 435.0% during the second quarter. Tower Research Capital LLC TRC now owns 225,616 shares of the technology company's stock worth $5,410,000 after buying an additional 183,444 shares in the last quarter. Finally, Millennium Management LLC raised its position in shares of Koninklijke Philips by 98.1% in the third quarter. Millennium Management LLC now owns 340,340 shares of the technology company's stock valued at $9,278,000 after buying an additional 168,514 shares during the last quarter. Institutional investors and hedge funds own 13.67% of the company's stock.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. NYSE: PHG, commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips' principal activities center on medical technologies and personal health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.